VANGUARD GROUP INC 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 166,301 4.360% | 79,871 (+92.41%) | Filing |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 86,430 5.960% | 86,430 (New Position) | Filing |